Pentadecanoic Acid for Healthy Aging

This trial aims to determine whether pentadecanoic acid (C15:0), a type of fatty acid, can enhance red blood cell health and reduce biological age in healthy adults over 55. Participants will receive either 200 mg or 300 mg of C15:0, or a placebo, daily for 12 weeks. Researchers will also assess inflammation, fatigue, sleep quality, and overall quality of life. This trial suits individuals over 55 who are healthy, on a stable medication plan, and can maintain consistent lifestyle habits. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to significant findings.

Research has shown that pentadecanoic acid (C15:0) is generally safe for humans. This natural fatty acid occurs in foods like dairy. Studies suggest it may support heart health and metabolism. Previous research involving people has not reported any major side effects. Since this trial is in the second phase, serious safety issues are unlikely, as earlier studies would have identified them. Overall, current evidence indicates that pentadecanoic acid is a safe choice.¹²³⁴⁵

Unlike the standard of care for healthy aging, which often includes lifestyle changes, supplements, and medications aimed at managing symptoms, Pentadecanoic Acid offers a unique approach by utilizing a naturally occurring fatty acid. Researchers are excited about this treatment because it introduces a novel active ingredient, C15:0, which may support cellular health and longevity. This fatty acid has the potential to enhance overall well-being at a cellular level, potentially providing a more foundational solution to healthy aging than current options.

Research has shown that pentadecanoic acid, a type of fatty acid, may help maintain cell health as people age. Early findings suggest it supports healthy red blood cells, potentially improving overall cell function. Some studies have found a link between higher levels of this fatty acid and better heart health, indicating it might help maintain health during aging. However, more research is needed to confirm these benefits specifically for older adults. This trial will evaluate the effects of pentadecanoic acid at different dosages, with some participants receiving 200 mg/day and others 300 mg/day, while a separate group will receive a placebo. Overall, evidence suggests that pentadecanoic acid has promising potential for supporting healthy aging.⁶⁷⁸⁹¹⁰